Abstract

The mucolytic human gut microbiota specialist Akkermansia muciniphila is proposed to boost mucin-secretion by the host, thereby being a key player in mucus turnover. Mucin glycan utilization requires the removal of protective caps, notably fucose and sialic acid, but the enzymatic details of this process remain largely unknown. Here, we describe the specificities of ten A. muciniphila glycoside hydrolases, which collectively remove all known sialyl and fucosyl mucin caps including those on double-sulfated epitopes. Structural analyses revealed an unprecedented fucosidase modular arrangement and explained the sialyl T-antigen specificity of a sialidase of a previously unknown family. Cell-attached sialidases and fucosidases displayed mucin-binding and their inhibition abolished growth of A. muciniphila on mucin. Remarkably, neither the sialic acid nor fucose contributed to A. muciniphila growth, but instead promoted butyrate production by co-cultured Clostridia. This study brings unprecedented mechanistic insight into the initiation of mucin O-glycan degradation by A. muciniphila and nutrient sharing between mucus-associated bacteria.

This study offers molecular insight into the sialidase and fucosidase decapping apparatus that initiates growth on mucin and promotes nutrient sharing by the dedicated mucolytic symbiont Akkermansia muciniphila with the mucus-associated microbiota.

Details

Title
Sialidases and fucosidases of Akkermansia muciniphila are crucial for growth on mucin and nutrient sharing with mucus-associated gut bacteria
Author
Shuoker, Bashar 1 ; Pichler, Michael J. 2   VIAFID ORCID Logo  ; Jin, Chunsheng 3   VIAFID ORCID Logo  ; Sakanaka, Hiroka 2 ; Wu, Haiyang 4 ; Gascueña, Ana Martínez 4   VIAFID ORCID Logo  ; Liu, Jining 5 ; Nielsen, Tine Sofie 2 ; Holgersson, Jan 5 ; Nordberg Karlsson, Eva 6   VIAFID ORCID Logo  ; Juge, Nathalie 4   VIAFID ORCID Logo  ; Meier, Sebastian 7   VIAFID ORCID Logo  ; Morth, Jens Preben 2   VIAFID ORCID Logo  ; Karlsson, Niclas G. 3   VIAFID ORCID Logo  ; Abou Hachem, Maher 2   VIAFID ORCID Logo 

 Technical University of Denmark, Department of Biotechnology and Biomedicine, Lyngby, Denmark (GRID:grid.5170.3) (ISNI:0000 0001 2181 8870); Lund University, Biotechnology, Department of Chemistry, Lund, Sweden (GRID:grid.4514.4) (ISNI:0000 0001 0930 2361) 
 Technical University of Denmark, Department of Biotechnology and Biomedicine, Lyngby, Denmark (GRID:grid.5170.3) (ISNI:0000 0001 2181 8870) 
 University of Gothenburg, Proteomics Core Facility at Sahlgrenska Academy, Gothenburg, Sweden (GRID:grid.8761.8) (ISNI:0000 0000 9919 9582) 
 Quadram Institute Bioscience, Norwich, UK (GRID:grid.40368.39) (ISNI:0000 0000 9347 0159) 
 University of Gothenburg, Department of Laboratory Medicine, Institute of Biomedicine, Sahlgrenska Academy, Gothenburg, Sweden (GRID:grid.8761.8) (ISNI:0000 0000 9919 9582) 
 Lund University, Biotechnology, Department of Chemistry, Lund, Sweden (GRID:grid.4514.4) (ISNI:0000 0001 0930 2361) 
 Technical University of Denmark, Department of Chemistry, Kgs Lyngby, Denmark (GRID:grid.5170.3) (ISNI:0000 0001 2181 8870) 
Pages
1833
Publication year
2023
Publication date
2023
Publisher
Nature Publishing Group
e-ISSN
20411723
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2793847176
Copyright
© The Author(s) 2023. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.